Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, February 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 3 X users

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,482 followers.

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases https://t.co/htkTdW9Emt #allergy #feedly

03 Feb 2021

Reply Repost Favourite

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases https://t.co/C3w8Q9QOZ1

03 Feb 2021

Reply Repost Favourite

重症AKCとVKCに対するタクロリムスの効果。 Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases | Allergy, Asthma & Clinical Immunology https://t.co/oc9FI3rULV

02 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.